{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:10:20Z","timestamp":1790633420335,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jinf.2020.09.024","type":"journal-article","created":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:30:40Z","timestamp":1601080240000},"page":"952-960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals"],"prefix":"10.1016","volume":"81","author":[{"given":"Ronald A.","family":"Seaton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L.","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Malcolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Dundas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Jeffreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayleigh","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Choo-Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Brittain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Sneddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2020.09.024_bib0001","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Association of adverse events with antibiotic use in hospitalized patients","volume":"177","author":"Tamma","year":"2017","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.jinf.2020.09.024_bib0002","unstructured":"UK Department of Health. Tackling Antimicrobial Resistance 2019 to 2024: the UK's 5-Year National Action Plan. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/784894\/UK_AMR_5_year_national_action_plan.pdf(accessed 7th July 2020)"},{"key":"10.1016\/j.jinf.2020.09.024_bib0003","unstructured":"Scottish Antimicrobial Prescribing Group. Scottish Reduction in Antimicrobial Prescribing (ScRAP)https:\/\/www.nes.scot.nhs.uk\/education-and-training\/by-theme-initiative\/healthcare-associated-infections\/training-resources\/scottish-reduction-in-antimicrobial-prescribing-(scrap).aspx(accessed 7th July 2020)"},{"key":"10.1016\/j.jinf.2020.09.024_bib0004","unstructured":"Seaton R.A COVID-19 and its Impact on Antimicrobial Stewardshiphttps:\/\/revive.gardp.org\/covid-19-and-its-impact-on-antimicrobial-stewardship\/(accessed 7th July 2020)"},{"key":"10.1016\/j.jinf.2020.09.024_bib0005","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2020.09.024_bib0006","unstructured":"International Severe Acute Respiratory and Emerging Infections (ISARIC) Report 27 April 2020https:\/\/ISARIC_Data_Platform_COVID-19_Report_27APR20.pdf(accessed 7th July 2020)"},{"key":"10.1016\/j.jinf.2020.09.024_bib0007","doi-asserted-by":"crossref","unstructured":"World Health Organisation. Clinical Management of Severe Acute Respiratory Infection (SARI) When COVID-19 Disease is Suspected. Interim Guidance. 13th March2020. https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/clinical-management-of-novel-cov.pdf","DOI":"10.15557\/PiMR.2020.0003"},{"key":"10.1016\/j.jinf.2020.09.024_bib0008","unstructured":"Langford B.J., So M., Raybardhan S., Leung V., Westwood D., MacFadden D R. et\u00a0al. Bacterial Co-Infection and Secondary Infection in Patients with COVID-19: a Living Rapid Review and Meta-analysis Clin Micro Infect, 10.1016\/j.cmi.2020.07.016"},{"key":"10.1016\/j.jinf.2020.09.024_bib0009","article-title":"Superinfections, and antimicrobial development: what can we expect?","author":"Cornelius","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.09.024_bib0010","unstructured":"Scottish Antimicrobial Prescribing Group. SAPG Response to COVID-19https:\/\/www.sapg.scot\/about-us\/latest-updates\/sapg-response-to-covid-19\/(accessed 7th July 2020)"},{"key":"10.1016\/j.jinf.2020.09.024_bib0011","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ijantimicag.2006.10.020","article-title":"Point prevalence survey of antibiotic use in Scottish hospitals utilising the glasgow antimicrobial audit tool (GAAT","volume":"29","author":"Seaton","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jinf.2020.09.024_bib0012","unstructured":"Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (2019 Global PPS)https:\/\/www.global-pps.com\/wp-content\/uploads\/2019\/02\/Global-PPS-2019-protocol.pdf(accessed 7th July 2020)"},{"key":"10.1016\/j.jinf.2020.09.024_bib0013","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/jac\/dky171","article-title":"Optimizing carbapenem use through a national quality improvement programme","volume":"73","author":"Robson","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2020.09.024_bib0014","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkaa096","article-title":"Thomson AH development and evaluation of a national gentamicin and vancomycin quality improvement programme","author":"Semple","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2020.09.024_bib0015","unstructured":"Scottish Government. Coronovirus (COVID-19) Trends in Daily Datahttps:\/\/www.gov.scot\/publications\/coronavirus-covid-19-trends-in-daily-data\/ (accessed 7th July 2020)"},{"key":"10.1016\/j.jinf.2020.09.024_bib0016","unstructured":"Health Protection Scotland. National Point Prevalence Survey of Healthcare Associated Infection and Antimicrobial Prescribing 2016 https:\/\/www.hps.scot.nhs.uk\/web-resources-container\/national-point-prevalence-survey-of-healthcare-associated-infection-and-antimicrobial-prescribing-2016\/"},{"key":"10.1016\/j.jinf.2020.09.024_bib0017","unstructured":"Public Health Scotland. Hospital onset COVID-19 Cases in Scotlandhttps:\/\/beta.isdscotland.org\/find-publications-and-data\/population-health\/covid-19\/ (accessed 7th July 2020)"},{"key":"10.1016\/j.jinf.2020.09.024_bib0018","doi-asserted-by":"crossref","unstructured":"Horby P., Lim W S., Emberson J. et\u00a0al. Effect of Dexamethasone in Hospitalised Patients with COVID-19: Preliminary Report pre-print doi: https:\/\/doi.org\/10.1101\/2020.06.22.20137273","DOI":"10.1101\/2020.06.22.20137273"},{"key":"10.1016\/j.jinf.2020.09.024_bib0019","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of COVID-19 \u2013 preliminary report","author":"Beigel","year":"2020","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jinf.2020.09.024_bib0020","unstructured":"Williams E.J., Mair L., de Silva I.T. et\u00a0al. Routine measurement of serum Procalcitonin allows antibiotics to be safely withheld in patients admitted to hospital with SARS-CoV-2 infection doi: https\/\/doi.org\/10.1101\/2020.06.29.20136572"},{"key":"10.1016\/j.jinf.2020.09.024_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2020.04.049","article-title":"COVID-19 and diabetes mellitus: an unholy interaction of two pandemics","author":"Pal","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.jinf.2020.09.024_bib0022","article-title":"Features of 20\u2009133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jinf.2020.09.024_bib0023","unstructured":"Wikramaratna P., Paton R.S., Ghafari M., Lourenco J. Estimating False-Negative Detection Rate of SARS-CoV-2 by RT-PCRhttps:\/\/www.medrxiv.org\/content\/10.1101\/2020.04.05.20053355v1.full.pdf"},{"key":"10.1016\/j.jinf.2020.09.024_bib0024","first-page":"155","article-title":"Restrictive antibiotic stewardship associated with reduced hospital mortality in gram-negative infection","volume":"110","author":"Ritchie","year":"2017","journal-title":"Quart J Med"},{"key":"10.1016\/j.jinf.2020.09.024_bib0025","unstructured":"Dhesi Z., Enne V.I., Brealey D. et\u00a0al. Organisms causing secondary pneumonia in COVID-19 patients in 5 UK ICUs as detected with the FilmArray testhttps:\/\/www.medrxiv.org\/content\/10.1101\/2020.06.22.20131573v1.full.pdf"},{"key":"10.1016\/j.jinf.2020.09.024_bib0026","unstructured":"Scottish Antimicrobial Prescribing Group. Good practice recommendations for the treatment of Candidaemia and use of antifungal agents (March 2019)https:\/\/www.sapg.scot\/media\/4612\/candidaemia-and-antifungal-agents.pdf(accessed 7th July 2020)"},{"key":"10.1016\/j.jinf.2020.09.024_bib0027","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3201\/eid2607.201603","article-title":"Fatal invasive aspergillosis and coronavirus disease in an immunocompetent patient","volume":"26","author":"Blaize","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jinf.2020.09.024_bib0028","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00134-012-2673-2","article-title":"Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study","volume":"38","author":"Wauters","year":"2012","journal-title":"Intensive Care Med"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320306162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320306162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:30:46Z","timestamp":1759008646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445320306162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0163445320306162"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2020.09.024","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2020.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}